Introduction Compared with breast cancer (BC) in women, BC in men is a rare disease with
genetic and molecular peculiarities. Therapeutic approaches for male BC (MBC) are …

Background Male breast cancer (BC) is rare, managed by extrapolation from female BC. The
International Male BC Program aims to better characterize and manage this disease. We …

Male breast cancer (MBC) is rare, with the peak age of onset at 71 years. BRCA2 mutations
are more frequent than BRCA1 with 20% of cases giving a family history. Risk factors for …

Male breast cancer is a rare disease, accounting for less than 1% of all breast cancer
diagnoses worldwide. Most data on male breast cancer comes from small single-institution …

Background Male breast cancer (MBC) is rare. Given the paucity of randomized trials,
treatment is generally extrapolated from female breast cancer guidelines. Methods This is a …

Background. Due to its rarity, male breast cancer (mBC) remains an inadequately
characterized disease, and current evidence for treatment derives from female breast cancer …

Male breast cancer is rare, accounting for 1% of all breast cancer diagnoses in the USA.
Because of its rarity, most major breast cancer trials have included only female patients. This …

Male breast cancer (MBC) is an uncommon disease with a frequency of approximately one
in 1000. Due to the rarity of MBC, it is understudied and its etiology is poorly understood. Our …

Background BRCA1 and, more commonly, BRCA2 mutations are associated with increased
risk of male breast cancer (MBC). However, only a paucity of data exists on the pathology of …

Background Male breast cancer (MBC) is rare. Molecular subtype has been utilized widely
in female breast cancer. But the relationship between subtype and prognosis in MBC …